Provided by Tiger Trade Technology Pte. Ltd.

Lantern Pharma Inc.

2.22
-0.0100-0.45%
Post-market: 2.220.00000.00%16:10 EDT
Volume:28.55K
Turnover:64.39K
Market Cap:24.83M
PE:-1.27
High:2.41
Open:2.24
Low:2.18
Close:2.23
52wk High:5.74
52wk Low:2.03
Shares:11.18M
Float Shares:8.59M
Volume Ratio:0.75
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7524
EPS(LYR):-1.9309
ROE:-104.58%
ROA:-55.99%
PB:2.59
PE(LYR):-1.15

Loading ...

Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Correspondence

Form CORRESP - Correspondence
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities